Innate Pharma Value At Risk
| IPHA Stock | | | USD 1.50 -0.05 -3.23% |
Innate Pharma value at risk lookup summarizes this and related technical indicators for Innate Pharma. Availability can vary by instrument;
Equity Screeners offers additional screening access. Innate Pharma has a market cap of 140.59 M, operating margin of -5.23%, ROE of -2.71%. Use
Risk vs Return Analysis to explore allocation context. This includes a position in Innate Pharma within the allocation view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in rate.
Interested in buying Innate Stock? Our
How to Buy Innate Pharma guide covers everything you need to know.
Innate Pharma has current Value At Risk of
-4.14. Value At Risk (or VAR) is a statistical technique used to measure the level of financial risk of investment instrument over a specific time frame. It is a widely used measure of the risk of loss on a specific investing instrument.
Value At Risk | = | ER[a] x N | + | (Z-SCORE x STD x SQRT (N)) |
| = | -4.14 | |
| ER[a] | = | Expected return on investing in Innate Pharma |
| STD | = | Standard Deviation of Innate Pharma |
| N | = | Number of points for the period |
| Z-SCORE | = | Number of standard deviations above or below the mean |
Innate Pharma Value At Risk Peers Comparison
Innate Value At Risk Relative To Other Indicators
Innate Pharma is rated
second in value at risk among leading competitors. It is currently under evaluation in maximum drawdown among leading competitors .
Value At Risk is used by risk managers in order to measure and control the level of risk which the firm undertakes. The risk manager job is to ensure that risks are not taken beyond the level at which the firm can absorb the losses of a probable worst outcome. VAR can be defined as the loss level that will not be exceeded with a certain confidence level during a certain period of time.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.